Response to the Letter re: Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed

Eur J Cancer. 2024 Nov:212:115057. doi: 10.1016/j.ejca.2024.115057. Epub 2024 Oct 2.

Authors

Alessandro Leonetti¹, Fabiana Perrone², Matteo Puntoni³, Giuseppe Maglietta³, Caterina Caminiti³, Marcello Tiseo⁴

Affiliations

¹ Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
² Medical Oncology Unit, University Hospital of Parma, Parma, Italy. Electronic address: [email protected].
³ Clinical & Epidemiological Research Unit, University Hospital of Parma, Parma, Italy.
⁴ Medical Oncology Unit, University Hospital of Parma, Parma, Italy; Department of Medicine and Surgery, University of Parma, Parma, Italy.

PMID: 39406597
DOI: 10.1016/j.ejca.2024.115057

No abstract available

Publication types

Letter